PRS Global Open • 2017 of severity. Each subject received a single dose of 6 mg betamethasone acetate. One month outcomes were analyzed to evaluate efficacy of steroid injection. These outcomes were further stratified based on baseline characteristics and stage of triggering.
RESULTS:
A total of 99 digits and 69 subjects were included. Two variables were found to be significant in predicting response to initial injection: 1. Multiple affected digits 2. Stage severity. Patients with multiple involved fingers were 5.8 times more likely to have no resolution of symptoms compared to those with a single affected finger. For every level of stage increase, the odds double for having no resolution of symptoms.
CONCLUSION:
Steroid injection remains a viable firstline option for patients presenting with mild triggering (Stage 1 and 2). For more severe triggering (Stage 3 and 4), or multiple affected digits, success of steroid injection is significantly lower at one month. For these patients, surgery may be a reasonable initial treatment. 
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DIAGNOSTIC TESTING REQUESTED BEFORE SURGICAL EVALUATION FOR
University of Michigan, Ann Arbor, MI, USA.
PURPOSE: We sought to evaluate how often physicians who perform carpal tunnel release (CTR) routinely request electrodiagnostic studies (EDS) or other tests prior to an initial consultation, and whether provider characteristics had an influence on testing requirements.
METHODS:
Through online data sources, we identified providers throughout the state of Michigan with profiles confirming surgical treatment of carpal tunnel syndrome (CTS). We recorded American Society for Surgery of the Hand (ASSH) membership, teaching facility status, practice size, and primary specialty for providers. Using a standardized telephone script, we contacted 219 providers by telephone to determine whether any diagnostic tests were needed before an appointment. Using multivariable logistic regression, we evaluated the relationship between the requirement for pre-consultation testing and surgeon characteristics.
RESULTS:
Among the 134 providers who were confirmed to perform CTR, 57% (n=76) required and 9% (n=12) recommended a diagnostic test prior to the initial consultation. EDS was requested by 56% (n=75), 14% (n=19) requested an MRI, 8% (n=11) requested a CT scan, and 6% (n=8) requested an X-ray. Patients were asked to have multiple studies by 19/88 (22%) of the surgeons who requested/recommended testing. ASSH membership, size of practice and teaching facility status did not have a significant relationship with pre-consultation testing requirements.
CONCLUSION:
The majority of surgeons who treat CTS use EDS indiscriminately, rather than reserving use of the test for patients with unclear diagnoses. Patients should be included in the decision to obtain tests if they are used for purposes other than informing treatment decisions. PURPOSE: Breast cancer surgical treatment may include large volume displacement oncoplastic surgery (LVOS) or mastectomy with free flap reconstruction (MFFR). Reduction mammaplasty designs are used in the oncoplastic reconstructions. The goal of this study was to investigate the cost-utility between LVOS versus MFFR to determine which approach was cost-effective in the treatment of breast cancer.
A COST-UTILITY ANALYSIS COMPARING
METHODS:
A review of the literature helped calculate probabilities for clinical outcomes for each surgical option (LVOS
